SK11472000A3 - Kvapalný farmaceutický prípravok obsahujúci zotepín - Google Patents

Kvapalný farmaceutický prípravok obsahujúci zotepín Download PDF

Info

Publication number
SK11472000A3
SK11472000A3 SK1147-2000A SK11472000A SK11472000A3 SK 11472000 A3 SK11472000 A3 SK 11472000A3 SK 11472000 A SK11472000 A SK 11472000A SK 11472000 A3 SK11472000 A3 SK 11472000A3
Authority
SK
Slovakia
Prior art keywords
acid
zotepine
composition
composition according
organic
Prior art date
Application number
SK1147-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Ann Margaret Dyer
Alan Smith
Original Assignee
Knoll Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Aktiengesellschaft filed Critical Knoll Aktiengesellschaft
Publication of SK11472000A3 publication Critical patent/SK11472000A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SK1147-2000A 1998-02-07 1999-01-27 Kvapalný farmaceutický prípravok obsahujúci zotepín SK11472000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802617.2A GB9802617D0 (en) 1998-02-07 1998-02-07 Pharmaceutical formulation
PCT/EP1999/000533 WO1999039709A1 (en) 1998-02-07 1999-01-27 Liquid pharmaceutical formulation containing zotepine

Publications (1)

Publication Number Publication Date
SK11472000A3 true SK11472000A3 (sk) 2001-08-06

Family

ID=10826622

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1147-2000A SK11472000A3 (sk) 1998-02-07 1999-01-27 Kvapalný farmaceutický prípravok obsahujúci zotepín

Country Status (25)

Country Link
US (1) US6239165B1 (de)
EP (1) EP1054666B1 (de)
JP (1) JP2002502818A (de)
KR (1) KR20010040717A (de)
AR (1) AR018062A1 (de)
AT (1) ATE227988T1 (de)
AU (1) AU2720099A (de)
BG (1) BG104682A (de)
BR (1) BR9907644A (de)
CA (1) CA2320475A1 (de)
CO (1) CO4970815A1 (de)
CZ (1) CZ291975B6 (de)
DE (1) DE69904021T2 (de)
DK (1) DK1054666T3 (de)
ES (1) ES2188135T3 (de)
GB (1) GB9802617D0 (de)
HK (1) HK1033088A1 (de)
HR (1) HRP20000579A2 (de)
HU (1) HUP0100769A3 (de)
PL (1) PL342213A1 (de)
PT (1) PT1054666E (de)
SK (1) SK11472000A3 (de)
TR (1) TR200002288T2 (de)
WO (1) WO1999039709A1 (de)
ZA (1) ZA99918B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006032427A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung
DE102006032426A1 (de) * 2006-07-13 2008-01-17 Neuraxpharm Arzneimittel Gmbh U. Co. Kg Verwendung von Zusammensetzungen von Clozapin, Quetiapin, schwer oder sehr schwer löslichen Säureadditionssalzen von Quetiapin und/oder Olanzapin zur Herstellung von Lösungen zur oralen Verabreichung

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1247067A (en) * 1968-02-16 1971-09-22 Fujisawa Pharmaceutical Co Tricyclic enol ether compounds and the preparation thereof
JPS5191315A (ja) * 1975-02-06 1976-08-10 Anteinaensantoruperizonshirotsupunoseizoho
JPS5852220A (ja) * 1981-09-24 1983-03-28 Fujisawa Pharmaceut Co Ltd 血清尿酸値低下剤
JPH07116039B2 (ja) * 1988-01-11 1995-12-13 オール薬品工業株式会社 安定な塩酸トリメトキノール内用液剤
ZA90341B (en) * 1989-01-23 1990-10-31 Merrell Dow Pharma Liquid pharmaceutical composition for piperidinoalkanol derivatives
US5462932A (en) * 1994-05-17 1995-10-31 Merck & Co., Inc. Oral liquid alendronate formulations
JPH0827034A (ja) * 1994-07-14 1996-01-30 Nikken Chem Co Ltd エリスリトール含有内用液剤
IL117612A0 (en) * 1995-03-24 1996-07-23 Lilly Co Eli Granule formulation for olanzapine
GB9526264D0 (en) * 1995-12-21 1996-02-21 Knoll Ag Medical treatment
JPH09286723A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 改善された経口液剤

Also Published As

Publication number Publication date
HUP0100769A2 (hu) 2001-12-28
EP1054666A1 (de) 2000-11-29
BR9907644A (pt) 2000-11-14
US6239165B1 (en) 2001-05-29
ZA99918B (en) 2000-08-07
CZ20002846A3 (cs) 2000-12-13
ES2188135T3 (es) 2003-06-16
KR20010040717A (ko) 2001-05-15
TR200002288T2 (tr) 2000-12-21
WO1999039709A1 (en) 1999-08-12
HRP20000579A2 (en) 2001-04-30
HK1033088A1 (en) 2001-08-17
DE69904021D1 (de) 2003-01-02
HUP0100769A3 (en) 2002-04-29
CA2320475A1 (en) 1999-08-12
AU2720099A (en) 1999-08-23
CO4970815A1 (es) 2000-11-07
EP1054666B1 (de) 2002-11-20
GB9802617D0 (en) 1998-04-01
ATE227988T1 (de) 2002-12-15
DK1054666T3 (da) 2003-03-17
PT1054666E (pt) 2003-03-31
DE69904021T2 (de) 2003-04-30
BG104682A (en) 2001-05-31
AR018062A1 (es) 2001-10-31
CZ291975B6 (cs) 2003-06-18
JP2002502818A (ja) 2002-01-29
PL342213A1 (en) 2001-05-21

Similar Documents

Publication Publication Date Title
EP1117440B1 (de) Paclitaxel enthaltende arzneimittel
CN100379419C (zh) 含有4,5-环氧***喃衍生物的稳定的药物组合物
EA035750B1 (ru) Водная фармацевтическая композиция тапентадола для перорального введения
US11938109B2 (en) Methods for the preparation of a levothyroxine solution
CZ292256B6 (cs) Farmaceutická směs a způsob její přípravy
SK1222001A3 (en) Pharmaceutical composition for injection based on paracetamol
WO2006129160A2 (en) Stable aqueous oral solution of risperidone
EP3811930A1 (de) Orale gliptinzusammensetzungen und verfahren zur herstellung davon
EP1946747A1 (de) Taxanderivat enthaltende pharmazeutische Zusammensetzung von verbesserter Stabilität
NZ552182A (en) Pharmaceutical composition of piperazine derivatives
SK11472000A3 (sk) Kvapalný farmaceutický prípravok obsahujúci zotepín
KR100776579B1 (ko) 수성 액제
US20210213024A1 (en) Liquid compositions of aprepitant
MXPA00007410A (es) Formulacion farmaceutica
JPH07112933A (ja) 安定な複合ビタミン内服液剤
JPH0283323A (ja) 安定な酪酸リボフラビン水溶液
JP5303086B2 (ja) 経口液剤
JP2011511059A (ja) 経口懸濁液用免疫抑制性マクロライド粉末
EP1757294A1 (de) Oral verabreichte wässrige risperidonlösung
JPH07258165A (ja) γ−オリザノール水溶液の安定化方法及び安定化されたγ−オリザノール水溶液
JPH07258082A (ja) ビタミンｅ製剤組成物
RU2173996C2 (ru) Фармацевтическая композиция, содержащая гидрохлорид тиагабина, и способ ее получения
JPH07116039B2 (ja) 安定な塩酸トリメトキノール内用液剤
KR20210081193A (ko) 몬테루카스트를 포함하는 투명 시럽 조성물
KR20180003413A (ko) 오셀타미비어 함유 경구용 고형제제 및 그 제조방법